Trending...
- A rare chance to own a multi-family property in the heart of Bay Ridge
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- CORPORATE IMMIGRATION PARTNERS, PC ANNOUNCES ANNE NAKAMURA HAS JOINED THE FIRM
CHICAGO, Oct. 8, 2024 ~ Chicago, IL - Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, showcased its leadership in driving innovative solutions for pharmaceutical companies at the PMSA 2024 Fall Symposium. The two-day summit, held on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare.
During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.
Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.
More on illi News
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:
- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.
- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.
More on illi News
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.
- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.
Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.
Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.
More on illi News
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Veterans and Young Job Seekers Get a Boost Through Mentor Agile's Expanded WIOA Support Program
- Build. Repair. Refresh – Summer Pond Projects Are in Full Swing!
- Lake Street Capital Partners Establishes New Residential Services Platform HighPoint Exterior Home Services by Partnering with Choufani & Bailey Roofing & Restoration
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:
- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.
- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.
More on illi News
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- CarobWay Launches Food-Forward Prebiotic Fiber Innovation at IFT
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.
- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.
Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
Filed Under: Business
0 Comments
Latest on illi News
- Universal Destinations & Experiences Plans Second Universal Horror Unleashed in Chicago
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Big Green Egg and Ace Hardware Launch "Egg Your Neighbor" Contest to Celebrate Neighborhood Heroes
- Pi9 Becomes a Microsoft Training Services Partner
- Endoacustica Europe Unveils iPhone 13 Pro Max Spy Phone—Pure Hardware, Zero Software Changes
- Suzanne Harp named Managing Director in Texas, USA
- $10 Million Acquisition of GXR World Sports Assets Energizes Global Launch of Sports.com Super App by Online Lottery-Sports Game Provider: Lottery.com
- Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
- Investor Spotlight: Cycurion, Inc. (N A S D A Q: CYCU) Secures $69M in Contracts Amid Surging Demand for AI-Powered Cybersecurity Solutions
- $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
- Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI
- VoodooSoft Unveils SiriusLLM: The World's First ChatGPT-Like AI Malware Detection Engine
- This Ain't Press. This Is Pressure — Star Command by RansomXX is Out Now
- Emerald Reimagined: Garden Party & Fundraiser to Celebrate Englewood's Bold Next Chapter
- An Exclusive VIP Reception Honoring Vocal Prodigy Alliana Lili Yang's Remarkable Achievements and Magazine Cover Spotlight
- Joyce Carol Oates Returns to Hard Case Crime With DOUBLE TROUBLE
- New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
- IQSTEL Surges Toward $400M Run Rate with $101.5M in Revenue—Reinforces Billion-Dollar Vision Backed by Fintech, AI, and Cybersecurity
- Alpha Modus Files 7th IP Action Against Rackspace Following $3M CEO Investment and Strategic Partnership Expansion
- Mortgage Rates And Demand Are Stuck In A Holding Pattern